Dexamethasone acetate (Standard)

Impurities

NP3104

1177-87-3

Dexamethasone acetate (Standard)

The acetate-protect form of Dexamethasone which is a glucocorticoid and could be used as an anti-inflammatory agent. It can be used for various inflammations, allergic diseases, bovine ketoneemia, sheep pregnancy toxemia, and can also be used for the simultaneous delivery of female animals.

DEXAMETHASONE ACETATE;1177-87-3;Dexamethasone 21-acetate;Decadronal;Decadron-LA;Panasone;Dexamethasone acetate anhydrous;Fortecortin (crystal suspension);Dectan;Dex-Cortidelt acetate;21-O-Acetyl Dexamethasone;CHEBI:4463;MFCD00027407;NSC 39471;NSC-39471;MLS000028544;MLS001148106;K7V8P532WP;Dexamethasone acetate, anhydrous;CHEMBL1530428;DTXSID8022901;9alpha-Fluoro-16alpha-methylprednisolone acetate;16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate;Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16alpha)-;SMR000058327;2-((8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate;Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-;9alpha-Fluoro-16alpha-methylprednisolone-21-acetate;9.alpha.-Fluoro-16.alpha.-methylprednisolone acetate;DTXCID402901;16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate;987-24-6;9-Fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate;Fortecortin (VAN);(11b,16a)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 21-acetate;dexamethason-21-acetate;UNII-K7V8P532WP;Dalalone DP;Dalalone LA;dexamethasone acetate, (6alpha,11beta)-isomer;NCGC00016566-01;Decadron-L.A.;Betamethasone Acetate Imp. B (EP); Dexamethasone Imp. G (EP); Betamethasone Acetate Impurity B; Dexamethasone Impurity G; Dexamethasone Isonicotinate Impurity B;Dexamethasoni acetas;Prestwick_157;CAS-1177-87-3;EINECS 214-646-8;Dexamethasone-acetate;Prednisolone F acetate;Dexamethasone (acetate);Decaject-L.A. (TN);Opera_ID_1620;Prestwick0_000130;Prestwick1_000130;Prestwick2_000130;Prestwick3_000130;BSPBio_000180;SCHEMBL136861;SPBio_002119;BPBio1_000198;Dexamethasoni acetas monohydrate;BRD5719;HMS1568I22;HMS2095I22;HMS2233A20;HMS3712I22;BCP28591;BRD-5719;Dexamethasone 21-acetate, >=99%;NSC39471;Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11b,16a)-;Tox21_110499;Tox21_112928;BDBM50103620;HY-14648A;s3124;AKOS015951406;DEXAMETHASONE ACETATE [USP-RS];DEXAMETHASONE ACETATE [WHO-DD];DEXAMETHASONE ACETATE [WHO-IP];Tox21_112928_1;CCG-220130;CS-1941;DB14649;DEXAMETHASONE 21-ACETATE [MI];9-Fluoro-11-beta,17,21-trihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione acetate;NCGC00022662-03;NCGC00022662-05;NCGC00022662-06;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate;2-((2S,10S,11S,15S,17S,1R,13R,14R)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl- 5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-oxoethyl ace tate;AS-13327;Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-, 21-acetate;DEXAMETHASONE ACETATE [EP MONOGRAPH];DEXAMETHASONI ACETAS [WHO-IP LATIN];DEXAMETHASONE ACETATE [USP MONOGRAPH];NS00073866;DEXAMETHASONE IMPURITY G [EP IMPURITY];C08174;D07796;EN300-19631802;SR-01000000099;SR-01000000099-2;W-108559;BETAMETHASONE ACETATE IMPURITY B [EP IMPURITY];BRD-K47635719-001-03-9;BRD-K47635719-001-21-1;Q27106392;Dodecahydro-3H-cyclopenta2-oxoethyl Acetate Dexamethasone;Z2417819627;Prednisolone, 9.alpha.-fluoro-16.alpha.-methyl-, acetate;Dexamethasone 21-acetate, VETRANAL(TM), analytical standard;Dexamethasone acetate, European Pharmacopoeia (EP) Reference Standard;Dexamethasone acetate, United States Pharmacopeia (USP) Reference Standard;Dexamethasone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material;Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-, 21-acetate;Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-, acetate;Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, acetate;[2-[(8R,9S,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate;2-[(1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate;9-Fluoro-11.beta.,17-dihydroxy-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate #;9alpha-Fluoro-16alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione-21-acetate;Pregna-1,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-;Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-, acetate;Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16alpha-methyl-, 21-acetate;

[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

434.50

C24H31FO6

C[C@@]1([C@@]2(O)C(COC(C)=O)=O)[C@](C[C@H]2C)([H])[C@@](CCC3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C1

InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17+,18+,19+,21+,22+,23+,24+/m1/s1

AKUJBENLRBOFTD-RPRRAYFGSA-N

579.4°C at 760 mmHg

219-222°C

97%

1.3 g/cm3

soluble in Chloroform, DMSO, Methanol

Solid

The acetate-protect form of Dexamethasone which is a glucocorticoid and could be used as a anti-inflammatory agent.

As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly

Please store the product under the recommended conditions in the Certificate of Analysis.

Powder

5 g